Form 8-K BIOMARIN PHARMACEUTICAL For: Aug 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall St futures decline as US-Iran escalation rattles sentiment
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- The real reason Meta shares are surging has nothing to do with its new AI model
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
BioMarin Pharma (BMRN) Enters $600M Revolving Credit Facility
September 4, 2024 12:57 PM EDTOn August 28, 2024, BioMarin Pharma (NASDAQ: BMRN), entered into a Credit Agreement (the Credit Agreement) with Citibank, N.A., as Administrative Agent (Citibank or the Administrative Agent), and the Lenders party thereto (the Lenders).
The Credit Agreement provides for up to $600 million in revolving loans (the Revolving Credit Facility), none of which was drawn at closing. Subject to the satisfaction of certain conditions precedent, the Company will be entitled to draw funds at its discretion until the Revolving Credit Facility matures on August 28, 2029 (the Maturity Date), at which time all outstanding loans shall become due and payable and all... More
